Drugs / Mannan Binding Lectin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00138736 | Apr 2004 → Oct 2006 | mannose-binding lectin deficiency, neutropenia | Prothya Biosolutions | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mannan Binding Lectin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00138736 ↗ |
| Known as | MBL | “Mannan Binding Lectin (MBL)” NCT00138736 ↗ |
| Action | Restore | “MBL replacement therapy” NCT00138736 ↗ |